News

On October 1st, 2026 American Antitrust Institute (AAI) honored Lowey Dannenberg, together alongside co-lead counsels, with its Outstanding Antitrust Litigation Achievement in Private Law Practice Award for our work in In re Amitiza Antitrust Litigation. In this action, Lowey team members served as lead counsel for the end-payor purchaser class, which resulted in a $63.2 million verdict in damages for…

The Super Lawyers list recognizes the top 5 percent of attorneys in each state. The Rising Stars list recognizes the top 2.5 percent of attorneys in each state. Partner and COO, Gerald Lawrence, Partner, Raymond Girnys, and Of Counsel, Peter Barile, we're recognized as Super Lawyers. Partner Amanda Fiorilla, and Senior Associates Nicole A. Veno, Anthony Christina, and Noelle Forde,…

On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. et al., No. 2:24-cv-00484 (E.D. Va.). In this case, Lowey Dannenberg represents CareFirst and a putative class of end payors against Amgen, alleging that Amgen engaged in a years-long scheme…

Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. Plaintiff allege that drug manufacturers Takeda and Sucampo, acting as partners, reached an anticompetitive agreement with generic manufacturer Par Pharmaceutical, Inc. in 2014, under which Par would delay market entry…

Lowey Dannenberg, P.C. is pleased to welcome its newest partner, Joseph Nielsen, to the firm. Joe built a storied career in private and public roles representing victims of antitrust conspiracies in the technology and pharmaceutical industries. During his 19 years at the Connecticut Attorney General’s Office, Joe gained extensive experience building antitrust cases from the ground up. After years of…